197 related articles for article (PubMed ID: 28376765)
21. Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients.
Kiyozumi Y; Matsubayashi H; Horiuchi Y; Higashigawa S; Oishi T; Abe M; Ohnami S; Urakami K; Nagashima T; Kusuhara M; Miyake H; Yamaguchi K
Cancer Med; 2019 Sep; 8(12):5534-5543. PubMed ID: 31386297
[TBL] [Abstract][Full Text] [Related]
22. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.
Buchanan DD; Tan YY; Walsh MD; Clendenning M; Metcalf AM; Ferguson K; Arnold ST; Thompson BA; Lose FA; Parsons MT; Walters RJ; Pearson SA; Cummings M; Oehler MK; Blomfield PB; Quinn MA; Kirk JA; Stewart CJ; Obermair A; Young JP; Webb PM; Spurdle AB
J Clin Oncol; 2014 Jan; 32(2):90-100. PubMed ID: 24323032
[TBL] [Abstract][Full Text] [Related]
23. Germline mutations in DNA repair genes may predict neoadjuvant therapy response in triple negative breast patients.
Spugnesi L; Gabriele M; Scarpitta R; Tancredi M; Maresca L; Gambino G; Collavoli A; Aretini P; Bertolini I; Salvadori B; Landucci E; Fontana A; Rossetti E; Roncella M; Naccarato GA; Caligo MA
Genes Chromosomes Cancer; 2016 Dec; 55(12):915-924. PubMed ID: 27328445
[TBL] [Abstract][Full Text] [Related]
24. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
[TBL] [Abstract][Full Text] [Related]
25. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.
Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D
BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974
[TBL] [Abstract][Full Text] [Related]
26. DNA-dependent protein kinase regulates DNA end resection in concert with Mre11-Rad50-Nbs1 (MRN) and ataxia telangiectasia-mutated (ATM).
Zhou Y; Paull TT
J Biol Chem; 2013 Dec; 288(52):37112-25. PubMed ID: 24220101
[TBL] [Abstract][Full Text] [Related]
27. The importance of making ends meet: mutations in genes and altered expression of proteins of the MRN complex and cancer.
Dzikiewicz-Krawczyk A
Mutat Res; 2008; 659(3):262-73. PubMed ID: 18606567
[TBL] [Abstract][Full Text] [Related]
28. Mismatch repair gene expression in gastroesophageal cancers.
Dracea A; Angelescu C; Danciulescu M; Ciurea M; Ioana M; Burada F
Turk J Gastroenterol; 2015 Sep; 26(5):373-7. PubMed ID: 26215063
[TBL] [Abstract][Full Text] [Related]
29. Integrated analysis of unclassified variants in mismatch repair genes.
Pastrello C; Pin E; Marroni F; Bedin C; Fornasarig M; Tibiletti MG; Oliani C; Ponz de Leon M; Urso ED; Della Puppa L; Agostini M; Viel A
Genet Med; 2011 Feb; 13(2):115-24. PubMed ID: 21239990
[TBL] [Abstract][Full Text] [Related]
30. Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome.
Schneider NB; Pastor T; Paula AE; Achatz MI; Santos ÂRD; Vianna FSL; Rosset C; Pinheiro M; Ashton-Prolla P; Moreira MÂM; Palmero EI;
Cancer Med; 2018 May; 7(5):2078-2088. PubMed ID: 29575718
[TBL] [Abstract][Full Text] [Related]
31. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.
Pugh TJ; Weeraratne SD; Archer TC; Pomeranz Krummel DA; Auclair D; Bochicchio J; Carneiro MO; Carter SL; Cibulskis K; Erlich RL; Greulich H; Lawrence MS; Lennon NJ; McKenna A; Meldrim J; Ramos AH; Ross MG; Russ C; Shefler E; Sivachenko A; Sogoloff B; Stojanov P; Tamayo P; Mesirov JP; Amani V; Teider N; Sengupta S; Francois JP; Northcott PA; Taylor MD; Yu F; Crabtree GR; Kautzman AG; Gabriel SB; Getz G; Jäger N; Jones DT; Lichter P; Pfister SM; Roberts TM; Meyerson M; Pomeroy SL; Cho YJ
Nature; 2012 Aug; 488(7409):106-10. PubMed ID: 22820256
[TBL] [Abstract][Full Text] [Related]
32. The MRN protein complex genes: MRE11 and RAD50 and susceptibility to head and neck cancers.
Ziółkowska-Suchanek I; Mosor M; Wierzbicka M; Rydzanicz M; Baranowska M; Nowak J
Mol Cancer; 2013 Sep; 12(1):113. PubMed ID: 24079363
[TBL] [Abstract][Full Text] [Related]
33. Pediatric duodenal cancer and biallelic mismatch repair gene mutations.
Roy S; Raskin L; Raymond VM; Thibodeau SN; Mody RJ; Gruber SB
Pediatr Blood Cancer; 2009 Jul; 53(1):116-20. PubMed ID: 19283792
[TBL] [Abstract][Full Text] [Related]
34. Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies.
Poley JW; Wagner A; Hoogmans MM; Menko FH; Tops C; Kros JM; Reddingius RE; Meijers-Heijboer H; Kuipers EJ; Dinjens WN;
Cancer; 2007 Jun; 109(11):2349-56. PubMed ID: 17440981
[TBL] [Abstract][Full Text] [Related]
35. DNA mismatch repair abnormalities in acinar cell carcinoma of the pancreas: frequency and clinical significance.
Liu W; Shia J; Gönen M; Lowery MA; O'Reilly EM; Klimstra DS
Pancreas; 2014 Nov; 43(8):1264-70. PubMed ID: 25058881
[TBL] [Abstract][Full Text] [Related]
36. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
Kim H; Cho DY; Choi DH; Oh M; Shin I; Park W; Huh SJ; Nam SJ; Lee JE; Kim SW
Breast Cancer Res Treat; 2017 Jan; 161(1):95-102. PubMed ID: 27783279
[TBL] [Abstract][Full Text] [Related]
37. DNA repair gene deficiency does not predispose human bronchial epithelial cells to benzo(a)pyrene-induced cell transformation.
Xing X; Liu C; Tang S; Li D; Chen L; Pang Y; Wang Q; Zhang B; Zeng X; Chen W; Xiao Y
Toxicol In Vitro; 2012 Jun; 26(4):579-84. PubMed ID: 22382310
[TBL] [Abstract][Full Text] [Related]
38. Analysis of DNA mismatch repair proteins in human medulloblastoma.
Lee SE; Johnson SP; Hale LP; Li J; Bullock N; Fuchs H; Friedman A; McLendon R; Bigner DD; Modrich P; Friedman HS
Clin Cancer Res; 1998 Jun; 4(6):1415-9. PubMed ID: 9626457
[TBL] [Abstract][Full Text] [Related]
39. Early-onset nucleotide excision repair disorders with neurological impairment: Clues for early diagnosis and prognostic counseling.
Baer S; Obringer C; Julia S; Chelly J; Capri Y; Gras D; Baujat G; Felix TM; Doray B; Sanchez Del Pozo J; Ramos LM; Burglen L; Laugel V; Calmels N
Clin Genet; 2020 Sep; 98(3):251-260. PubMed ID: 32557569
[TBL] [Abstract][Full Text] [Related]
40. Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.
Cowman S; Fan YN; Pizer B; Sée V
BMC Cancer; 2019 Apr; 19(1):300. PubMed ID: 30943920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
